Loading...
OTCMGSAC
Market cap154kUSD
Dec 24, Last price  
0.00USD
1D
-16.67%
1Q
-16.67%
Jan 2017
-86.49%
Name

Gelstat Corp

Chart & Performance

D1W1MN
OTCM:GSAC chart
P/E
—
P/S
1.03
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
21.14%
Rev. gr., 5y
-35.24%
Revenues
150k
+6,309.22%
1,750,6231,150,37348,0353,05200244,850338,039233,97518,17823,01921,44615,8931,312,6750201,00007,0222,333149,527
Net income
-210k
L-72.40%
-186,498-1,961,083-685,052-117,0631,462,505-1,473,109-6,222,975-5,792,011-1,817,827-1,083,466-463,060464,102-407,391-1,297,516-8,839175,000-177,838-475,243-761,185-210,111
CFO
-106k
L-38.34%
-181,069190,888-262,878-148,725-343,585-1,086,181-5,649,837-1,982,763-488,056-162,132-85,382-223,201-145,415-239,158-275,040-172,000-85,219-204,858-172,376-106,289

Profile

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. GelStat Corporation is headquartered in Palm City, Florida.
URL
https://www.gelstat.com/
IPO date
Apr 23, 1993
Employees
2
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122014‑12
Income
Revenues
150
6,309.22%
2
-66.78%
7
 
Cost of revenue
315
530
320
Unusual Expense (Income)
NOPBT
(166)
(528)
(313)
NOPBT Margin
Operating Taxes
(452)
(319)
Tax Rate
NOPAT
(166)
(76)
6
Net income
(210)
-72.40%
(761)
60.17%
(475)
167.23%
Dividends
Dividend yield
Proceeds from repurchase of equity
100
BB yield
Debt
Debt current
66
102
197
Long-term debt
517
274
25
Deferred revenue
Other long-term liabilities
(1)
(1)
Net debt
559
374
156
Cash flow
Cash from operating activities
(106)
(172)
(205)
CAPEX
(1)
Cash from investing activities
Cash from financing activities
130
107
271
FCF
(178)
147
72
Balance
Cash
25
2
67
Long term investments
Excess cash
18
2
67
Stockholders' equity
(2,739)
(13,374)
(13,891)
Invested Capital
2,545
13,031
13,772
ROIC
0.04%
ROCE
85.25%
154.33%
263.41%
EV
Common stock shares outstanding
1,304,470
621,861
512,926
Price
Market cap
EV
EBITDA
(118)
(528)
(313)
EV/EBITDA
Interest
42
17
230
Interest/NOPBT